Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):357-61.

2.

Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.

Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, Jenness SM, Melville SK, Burt R, Thiede H, Al-Tayyib A, Pannala PR, Miles IW, Oster AM, Smith A, Finlayson T, Bowles KE, Dinenno EA.

Clin Infect Dis. 2011 Oct;53(8):780-6. doi: 10.1093/cid/cir499.

PMID:
21921221
3.

Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.

Coyle C, Viner K, Hughes E, Kwakwa H, Zibbell JE, Vellozzi C, Holtzman D; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):459-63.

4.

Testing for HCV infection: an update of guidance for clinicians and laboratorians.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):362-5.

5.

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ.

Ann Intern Med. 2006 May 16;144(10):705-14.

PMID:
16702586
6.

The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.

Gidding HF, Topp L, Middleton M, Robinson K, Hellard M, McCaughan G, Maher L, Kaldor JM, Dore GJ, Law MG.

J Gastroenterol Hepatol. 2009 Oct;24(10):1648-54.

PMID:
19798783
7.

Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011-2014.

Koneru A, Nelson N, Hariri S, Canary L, Sanders KJ, Maxwell JF, Huang X, Leake JA, Ward JW, Vellozzi C.

MMWR Morb Mortal Wkly Rep. 2016 Jul 22;65(28):705-10. doi: 10.15585/mmwr.mm6528a2.

8.

Disease surveillance among newly arriving refugees and immigrants--Electronic Disease Notification System, United States, 2009.

Lee D, Philen R, Wang Z, McSpadden P, Posey DL, Ortega LS, Weinberg MS, Brown C, Zhou W, Painter JA; Centers for Disease Control and Prevention.

MMWR Surveill Summ. 2013 Nov 15;62(7):1-20.

9.

Rapid hepatitis C testing among persons at increased risk for infection--Wisconsin, 2012-2013.

Stockman LJ, Guilfoye SM, Benoit AL, Vergeront JM, Davis JP; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Apr 11;63(14):309-11.

10.

Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.

Hsieh YH, Rothman RE, Laeyendecker OB, Kelen GD, Avornu A, Patel EU, Kim J, Irvin R, Thomas DL, Quinn TC.

Clin Infect Dis. 2016 May 1;62(9):1059-65. doi: 10.1093/cid/ciw074. Epub 2016 Feb 21.

11.

Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965.

Cartwright EJ, Rentsch C, Rimland D.

BMC Res Notes. 2014 Jul 14;7:449. doi: 10.1186/1756-0500-7-449.

12.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G; National HIV Behavioral Surveillance System Study Group.

MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.

13.

Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.

Mera J, Vellozzi C, Hariri S, Carabin H, Drevets DA, Miller A, Reilley B, Essex W, Gahn D, Lyons L, Leston J, Ward JW.

MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):461-6. doi: 10.15585/mmwr.mm6518a2.

14.

Half a diagnosis: gap in confirming infection among hepatitis C antibody-positive patients.

McGibbon E, Bornschlegel K, Balter S.

Am J Med. 2013 Aug;126(8):718-22. doi: 10.1016/j.amjmed.2013.01.031. Epub 2013 Jun 17.

PMID:
23786667
15.

Locations and reasons for initial testing for hepatitis C infection--chronic hepatitis cohort study, United States, 2006-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Aug 16;62(32):645-8.

16.

Outcome of screening for hepatitis C virus infection based on risk factors.

Mallette C, Flynn MA, Promrat K.

Am J Gastroenterol. 2008 Jan;103(1):131-7. Epub 2007 Sep 25.

PMID:
17894850
17.

[Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].

Contreras AM, Ochoa-Jiménez RJ, Kershenobich D, Granados-García V, Conde-González CJ, Celis A, Pérez-Gómez HR, Ruelas-Hernández S, Romero-Flores P, Alcántar-Luna E, Sierra-García de Quevedo J, Ancona-Pisté O; Grupo de Desarrollo de la Guía.

Rev Invest Clin. 2012 Nov-Dec;64(6 Pt 2):641-78. Spanish.

PMID:
23593783
18.

Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.

Mahajan R, Liu SJ, Klevens RM, Holmberg SD.

Am J Public Health. 2013 Aug;103(8):1445-9. doi: 10.2105/AJPH.2013.301211. Epub 2013 Jun 13.

19.

Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010.

Spradling PR, Tong X, Rupp LB, Moorman AC, Lu M, Teshale EH, Gordon SC, Vijayadeva V, Boscarino JA, Schmidt MA, Holmberg SD; Chronic Hepatitis Cohort Study (CHeCS) Investigators.

Clin Infect Dis. 2014 Oct;59(7):976-81. doi: 10.1093/cid/ciu509. Epub 2014 Jul 2.

PMID:
24991025
20.

Tests and screening strategies for the diagnosis of hepatitis C.

Carey W.

Cleve Clin J Med. 2003 Sep;70 Suppl 4:S7-13. Review.

PMID:
14558640

Supplemental Content

Support Center